TABLE 3.

Decreases in anti-Anisakis IgE antibody levels in CAP FEIA, Ani s 1 ELISA, and Ani s 7 ELISA observed for sera from 15 positive patients at the end of the follow-up period^a

Patient no.	% Decrease in IgE antibody			Elapsed time (months)
	CAP FEIA	Ani s 1 ELISA	Ani s 7 ELISA
1	52.52	52.52	82.62	38
2	73.05	28.52	73.00	38
3	41.60	88.04	82.36	21
4	77.33	28.77	69.14	16
5	65.76	14.00	54.16	6
6	35.75	12.84	69.36	13
7	90.53	32.76	74.00	35
8	72.78	12.33	45.09	10
9	65.47	41.12	58.00	9
10	94.32	78.67	70.50	30
11	58.28	29.56	78.44	14
12	53.44	17.20	17.76	7
13	70.49	38.37	81.72	10
14	71.15	0.00	20.10	14
15	46.01	52.23	30.03	9
Mean ± SE	60.41 ± 5.77	35.12 ± 6.35	64.56 ± 4.34	18.00 ± 2.97

^aThe percent variations in IgE values were calculated using the first and last available samples from each investigated patient. Significant differences (P < 0.01) between Ani s 1 and Ani s 7 ELISAs and between CAP FEIA and Ani s 1 ELISA were observed.